Laboratory Corp American Holdings (NY:LH)

323.13 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal ↗

April 25, 2024

Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's...

Via Benzinga

LH Stock Earnings: Laboratory Corp Beats EPS, Beats Revenue for Q1 2024 ↗

April 25, 2024

LH stock results show that Laboratory Corp beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp

April 01, 2024

From Xcell Biosciences Inc.

Via Business Wire

Labcorp Expands Diagnostic Reach With Strategic Deal For Select Assets Of BioReference Health ↗

March 28, 2024

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5...

Via Benzinga

Laboratory Corp's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗

February 21, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

7 Analysts Have This to Say About Laboratory Corp ↗

November 17, 2023

Via Benzinga

Why Fortrea Holdings Shares Are Gaining Today ↗

October 17, 2023

Activist hedge fund Starboard Value holds a

Via Benzinga

LifeMD Shares Come Back to Life on GLP-1 Business Growth

March 19, 2024

LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024

Via MarketBeat

Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns ↗

January 12, 2024

A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection.

Via Benzinga

Laboratory Corp. of America Holdings (NYSE: LH) Records 52-Week High Tuesday Morning

January 02, 2024

Via Investor Brand Network

LifeMD expands telehealth GLP-1weight-loss service with Medifast

December 19, 2023

LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing

Via MarketBeat

Bear Of The Day: Labcorp ↗

September 19, 2023

Analysts have slashed their earnings expectations for the company, pushing it down to a Zacks Rank #5 (Strong Sell).

Via Talk Markets

Expert Ratings for Laboratory Corp ↗

September 06, 2023

Via Benzinga

Where Laboratory Corp Stands With Analysts ↗

August 14, 2023

Via Benzinga

Healthcare Sector Stocks: Consistent Above-Average Growth And Income ↗

December 18, 2023

The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.

Via Talk Markets

2 aerospace stocks are ready to take flight on the next leg up

December 18, 2023

The aerospace sector has been red hot in 2023; here are two surging aerospace stocks with the potential to reach even higher altitudes

Via MarketBeat

SLB, Marvell Technology And 2 Other Stocks Insiders Are Selling ↗

November 21, 2023

The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today ↗

November 13, 2023

The company's first quarter as a separate entity was better than anticipated.

Via The Motley Fool

Expert Ratings for Laboratory Corp ↗

July 28, 2023

Via Benzinga

Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready ↗

October 11, 2023

Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are...

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

The 7 Most Undervalued Value Stocks to Buy Now: August 2023 ↗

August 17, 2023

While it’s difficult to ignore the hot flavors of the week, investors should target these undervalued value stocks for the best bargains.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors

August 08, 2023

From Singular Genomics Systems, Inc.

Via GlobeNewswire

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

July 24, 2023

From Enzo Biochem, Inc.

Via GlobeNewswire

Visualizing The Entire S&P 500 ↗

July 14, 2023

One of the biggest challenges market analysts have is how to visualize the companies that make up the S&P 500.

Via Talk Markets

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 03, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.